Multicenter Phase II Trial of Lenvatinib plus Hepatic Intra-Arterial Infusion Chemotherapy with Cisplatin for Advanced Hepatocellular Carcinoma: LEOPARD — Masafumi Ikeda (2023) | RDL Network
Multicenter Phase II Trial of Lenvatinib plus Hepatic Intra-Arterial Infusion Chemotherapy with Cisplatin for Advanced Hepatocellular Carcinoma: LEOPARD
Article 2023 en
Authors
MI
Masafumi Ikeda
TY
Tatsuya Yamashita
SO
Sadahisa Ogasawara
Abstract
1 min read
Lenvatinib plus HAIC with cisplatin yielded a favorable ORR and overall survival and was well tolerated in patients with advanced HCC. Further evaluation of this regimen in a phase III trial is warranted.
Discussion(0)
No comments yet. Be the first to comment.